Cough, cold and allergy (hay fever) remedies will benefit from the increased health concerns during COVID-19 in 2020, as these products are aimed at some of the key symptoms of COVID-19. Like analgesics, this category is expected to show quite strong growth in the first quarter of 2020, with significant gains across all subcategories.
The Theraflu brand is indisputably the leader of cough, cold and allergy (hay fever) remedies. Introduced to the category relatively recently, Theraflu has led the category since 2017, and is expected to increase its value share once more in 2020.
In general, local manufacturers are not very successful in this category. Domestic manufacturers tend to struggle against significant competition from global players who have developed a very good reputation as effective products in tackling diseases.
Combination products remains the most popular product, due to the convenience offered by all-in-one products. The success of combination products is expected to continue to lead growth in the cough, cold and allergy (hay fever) remedies category throughout the forecast period.
Cough, cold and allergy (hay fever) remedies will continue to demonstrate good growth during the forecast period in general. This growth is expected to be led by volume growth in combination products, whilst paediatric cough, cold and allergy remedies is expected to lead retail current value growth in the forecast period.
It can be assumed that cough, cold and allergy (hay fever) remedies will remain one of the least fragmented categories during the forecast period. Although the local government is trying to boost the share of local manufacturers in OTC products as a whole, with well-developed expertise and advertising of global players β especially those producing combination products β global players are expected to continue to outperform local companies in the forecast period.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Uzbekistan with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Uzbekistan, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Cough, Cold and Allergy (Hay Fever) Remedies research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page